Precursor cell

Novel Antibody Therapies Market, 2035 - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 1, 2022
Health, Pharmaceutical, Growth, Lymphoma, Administration, Hairy cell leukemia, Antibody, Membrane protein, Combination therapy, Cell, Acute myeloid leukemia, Precursor cell, Partnership, Prostate, Graft-versus-host disease, Prostate cancer, Protein, T-cell lymphoma, Urinary bladder, Soft-tissue sarcoma, Bladder cancer, Research, Therapy, Immunotoxin, Mycosis fungoides, Publication, Type, B-cell lymphoma, Hodgkin lymphoma, Vaccine, Risk management, Pharmaceutical industry

The "Novel Antibody Therapies Market: Distribution by Type of Novel Antibody, Target Indication, Type of Therapy, Route of Administration, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Novel Antibody Therapies Market: Distribution by Type of Novel Antibody, Target Indication, Type of Therapy, Route of Administration, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.
  • The 'Novel Antibody Therapies Market, 2022-2035' report features an extensive study on the current market landscape, offering an informed opinion on the likely evolution of the novel antibody therapies in the treatment of various diseases.
  • What are the different initiatives undertaken by big pharma players for the development of novel antibody therapies in the recent past?
  • How is the current and future market opportunity, related to novel antibody therapies likely to be distributed across key market segments?

Private Stash by Chalice Brands Expands Product Line with New Peace Puck Concentrates

Retrieved on: 
Thursday, October 20, 2022
Efficiency, Chalice, Precursor cell, Company, Learning, Health, Genetics, Crumble, Solvent, Private, Coffee

Portland, Oregon--(Newsfile Corp. - October 20, 2022) - Private Stash by Chalice Brands recently introduced their newest concentrate line, Peace Pucks, in both Sugar Sauce and Crumble consistencies.

Key Points: 
  • Portland, Oregon--(Newsfile Corp. - October 20, 2022) - Private Stash by Chalice Brands recently introduced their newest concentrate line, Peace Pucks, in both Sugar Sauce and Crumble consistencies.
  • Aimed at connoisseurs who are looking for strain-specific products, the Peace Puck joins the rest of Private Stash's range of convenient, high-value cannabis products available at all Chalice Farms Cannabis Market locations across Oregon.
  • The efficiency of this extraction process allows Private Stash to offer these products more affordably in Oregon.
  • The Peace Puck will be available in a variety of different strains, including the legacy genetics that Private Stash is known for.

Planet Smoothie Opens in the Land Down Under with Plans to Expand

Retrieved on: 
Monday, August 22, 2022
Kahala Brands, Planet Smoothie, MTY, CEO, Cold Stone Creamery, MTY Food Group, TikTok, QSR, Sale, Planet, LinkedIn, Pleasure, Baja Fresh, Multimedia, Instagram, Social media, SEDAR, Taste, Industry, Mission statement, TacoTime, Fast food, Retail, CBD, Docklands, Precursor cell, Central business district, Kahala, Facebook, Thai Express

Kahala Brands, the franchisor and owner of the Planet Smoothie brand, has collaborated with Smoothie Group Pty.

Key Points: 
  • Kahala Brands, the franchisor and owner of the Planet Smoothie brand, has collaborated with Smoothie Group Pty.
  • Planet Smoothie fills the need of Australian consumers looking for a broader range of options and a high level of customer service.
  • The opportunity to bring a new player into the Australia Smoothie market was evident and the perfect match was Planet Smoothie."
  • Ltd. and Kahala Brands will work together to expand the Planet Smoothie brand with plans to open multiple locations within the next five years.

Magenta Therapeutics Reports First Quarter Financial Results, Early Clinical Observations from MGTA-117 Clinical Trial and Other Program Highlights

Retrieved on: 
Monday, May 16, 2022
Research, Clinical Trials, Stem Cells, Biotechnology, Health, Pharmaceutical, General Health, Other Science, Science, B cell, Disease, Blood, CD45, Haematopoietic system, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Research, Food, U.S. Securities and Exchange Commission, Degenerative disease, SCD, Leadership, Patient, AML, Disclosure, Sickle cell disease, Uncertainty, Goal, Bone marrow, Private Securities Litigation Reform Act, Therapy, Clinical trial, Precursor cell, COVID-19, Objective, Cell, Collection, IND, Lists of diseases, Magenta, Lymphatic system, Cohort, Biotechnology, Bluebird bio, Program, Safety, Neoplasm, Lymphocyte, Administration, Development, Myelodysplastic syndrome, Security (finance), Achievement, Bone, Pharmaceutical industry, Medical imaging, Vaccine

Magenta is conducting a Phase 1/2 dose-escalation clinical trial of MGTA-117 in patients with relapsed/refractory acute myeloid leukemia (AML) and myelodysplastic syndrome with excess blasts (MDS-EB).

Key Points: 
  • Magenta is conducting a Phase 1/2 dose-escalation clinical trial of MGTA-117 in patients with relapsed/refractory acute myeloid leukemia (AML) and myelodysplastic syndrome with excess blasts (MDS-EB).
  • Clinical Trial Status and Scope of Early Clinical Observations.
  • The clinical trial has progressed from Cohort 1 to Cohort 2 after meeting all protocol requirements for dose escalation.
  • Clinical observations were made from a preliminary data set from Cohort 1 which utilizes the trials lowest dose of MGTA-117 (0.02 mg/kg).

Jolt Launches Digital Communication Tool: Jolt Communication Manager

Retrieved on: 
Tuesday, November 9, 2021
Restaurant, CEO, Founder CEO, Communication, Tablet, Multimedia, SMS, Precursor cell, Announcement, Mobile phone

LEHI, Utah, Nov. 9, 2021 /PRNewswire/ -- Jolt Software, the leader in digital food safety and operations execution software for restaurants, has launched a new product called Jolt Communication Manager.

Key Points: 
  • LEHI, Utah, Nov. 9, 2021 /PRNewswire/ -- Jolt Software, the leader in digital food safety and operations execution software for restaurants, has launched a new product called Jolt Communication Manager.
  • Designed to streamline communication between operators and their employees and stores, Jolt Communication Manager ensures that critical information is delivered to the right people, at the right time, in the right way, through two features: Announcements and Message Blasts.
  • After the notification is shown, follow up questions can be displayed to ensure that the employee understood the communication.
  • That's what Jolt Communication Manager does," stated Josh Bird, Founder & CEO of Jolt.

Scientists Define the Role for a Rare, Influential Set of Bone Marrow Cells

Retrieved on: 
Tuesday, April 23, 2019
Branches of biology, Biology, Stem cells, Mesenchymal stem cell, Osteoblast, Bone, Adipocyte, Precursor cell, Muse cell, Induced stem cells

Such cells are thought to influence whether early stem cells mature into different types of other cells, such as red or white blood cells.

Key Points: 
  • Such cells are thought to influence whether early stem cells mature into different types of other cells, such as red or white blood cells.
  • Reporting in the journal Nature online in April, the study authors describe how they used a combined imaging-mapping tool to track the genetic function one by one of 17,374 mouse bone marrow cells.
  • Most were identified as cells that line blood vessels (i.e., vascular endothelial cells) or stem cells (mesenchymal cells) that make up bone (osteoblasts).
  • Among the stress-induced changes was that one set of stem cells (also mesenchymal), which typically develop into osteoblasts or muscle cells, in this instance only turned into fat cells (adipocytes).